1. Home
  2. LEA vs MDGL Comparison

LEA vs MDGL Comparison

Compare LEA & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lear Corporation

LEA

Lear Corporation

HOLD

Current Price

$116.28

Market Cap

5.4B

ML Signal

HOLD

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$583.62

Market Cap

12.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEA
MDGL
Founded
1917
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
12.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LEA
MDGL
Price
$116.28
$583.62
Analyst Decision
Buy
Strong Buy
Analyst Count
12
14
Target Price
$117.33
$580.77
AVG Volume (30 Days)
722.8K
282.8K
Earning Date
02-05-2026
11-04-2025
Dividend Yield
2.65%
N/A
EPS Growth
N/A
N/A
EPS
8.17
N/A
Revenue
$22,985,100,000.00
$740,640,000.00
Revenue This Year
N/A
$435.63
Revenue Next Year
$1.84
$52.56
P/E Ratio
$14.26
N/A
Revenue Growth
N/A
864.21
52 Week Low
$73.85
$265.00
52 Week High
$119.25
$615.00

Technical Indicators

Market Signals
Indicator
LEA
MDGL
Relative Strength Index (RSI) 62.48 57.00
Support Level $104.38 $535.33
Resistance Level $117.47 $615.00
Average True Range (ATR) 2.11 18.93
MACD -0.03 -1.05
Stochastic Oscillator 77.97 60.61

Price Performance

Historical Comparison
LEA
MDGL

About LEA Lear Corporation

Lear Corp designs, develops, and manufactures automotive seating and electrical systems and components. The company has two reporting segments Seating and E-Systems. Seating components include frames and mechanisms, covers (leather and woven fabric), seat heating and cooling, foam, and headrests. Automotive electrical distribution and connection systems and electronic systems include wiring harnesses, terminals and connectors, on-board battery chargers, high-voltage battery management systems. The company earns majority of its revenue from the seating segment.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

Share on Social Networks: